569 related articles for article (PubMed ID: 12582022)
1. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
[TBL] [Abstract][Full Text] [Related]
2. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
[TBL] [Abstract][Full Text] [Related]
3. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
7. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite profile in hormonal receptor genes associated with breast cancer.
Iobagiu C; Lambert C; Normand M; Genin C
Breast Cancer Res Treat; 2006 Jan; 95(2):153-9. PubMed ID: 16317584
[TBL] [Abstract][Full Text] [Related]
9. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.
Giguère Y; Dewailly E; Brisson J; Ayotte P; Laflamme N; Demers A; Forest VI; Dodin S; Robert J; Rousseau F
Cancer Res; 2001 Aug; 61(15):5869-74. PubMed ID: 11479228
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.
Liede A; Zhang W; De Leon Matsuda ML; Tan A; Narod SA
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):848-52. PubMed ID: 14504193
[TBL] [Abstract][Full Text] [Related]
12. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: a case-control study.
Mehdipour P; Pirouzpanah S; Kheirollahi M; Atri M
Breast J; 2011; 17(1):39-46. PubMed ID: 21159020
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
[TBL] [Abstract][Full Text] [Related]
17. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
Montgomery KG; Chang JH; Gertig DM; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
Breast Cancer Res; 2005; 7(3):R353-6. PubMed ID: 15987430
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women.
Yu MW; Yang YC; Yang SY; Chang HC; Liaw YF; Lin SM; Liu CJ; Lee SD; Lin CL; Chen PJ; Lin SC; Chen CJ
Hepatology; 2002 Jul; 36(1):156-63. PubMed ID: 12085360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]